Table 3.
Overall Use of Acid-Suppressive Drugs during the Hospital Stay (Phase 2 Interventions versus Phase 1 Historical Controls)
| Group | No. | No. of Patients Using ASMs | Patients Using ASMs (%) | PValue |
|---|---|---|---|---|
| Historical controls Phase 1 (2005) | 257 | 170 | 66% | — |
| Intervention A Phase 2 (2006, IBC alone) | 242 | 152 | 62% | NS |
| Intervention B Phase 2 (2006, IBC + BML) | 144 | 77 | 53% | 0.025 |
| Intervention C Phase 2 (2006, IBC + BML + CPI) | 137 | 73 | 53% | 0.025 |
ASM = acid-suppressive medication (either a histamine H2 antagonist or a proton pump inhibitor); IBC = intern boot camp; BML = beginning-of-month lecture; CPI = clinical pharmacist intervention; No. = total number of patients admitted on service; NS = not statistically significant.